Rybelsus Rybelsus photo

Rybelsus®(Semaglutide)

Diabetes, Obesity

Rybelsus® tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus® can be prescribed when other diabetes medicines have been tried without success and should be used together with diet and exercise. Rybelsus® tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating.

Package Price Per tablet Savings Order
3mg × 90 tablets
Free AirMail shipping
lei
6159.96
lei
68.44
lei
2051.57
Add to cart
3mg × 60 tablets
Free AirMail shipping
lei
4380.35
lei
73.01
lei
1094.00
Add to cart
3mg × 30 tablets
Free AirMail shipping
lei
2326.95
lei
77.57
lei 410.22 Add to cart
3mg × 20 tablets
Free AirMail shipping
lei
1642.49
lei
82.12
lei 182.30 Add to cart
Package Price Per tablet Savings Order
7mg × 90 tablets
Free AirMail shipping
lei
7391.99
lei
82.13
lei 819.53 Add to cart
7mg × 60 tablets
Free AirMail shipping
lei
5064.81
lei
84.41
lei 409.54 Add to cart
7mg × 30 tablets
Free AirMail shipping
lei
2600.74
lei
86.69
lei 136.44 Add to cart
7mg × 20 tablets
Free AirMail shipping
lei
1779.38
lei
88.97
lei 45.40 Add to cart
Package Price Per tablet Savings Order
14mg × 90 tablets
Free AirMail shipping
lei
8829.37
lei
98.10
lei
1024.87
Add to cart
14mg × 60 tablets
Free AirMail shipping
lei
6023.06
lei
100.38
lei 546.43 Add to cart
14mg × 30 tablets
Free AirMail shipping
lei
3079.86
lei
102.66
lei 204.88 Add to cart
14mg × 20 tablets
Free AirMail shipping
lei
2098.80
lei
104.94
lei 91.03 Add to cart
Most popular quantity.

Rybelsus® tablets

What is Rybelsus?

Rybelsus tablets (semaglutide) is a prescription medicine used in adults with type 2 diabetes mellitus to decrease blood sugar levels. Rybelsus can be prescribed when other diabetes medicines have been tried without success, and should be used together with diet and exercise.

Rybelsus tablets work to lower blood sugar (glucose) levels by increasing how much insulin is released and decreasing glucagon secretion. This medicine also may slow gastric emptying after eating. Rybelsus is from the class of medicines called GLP-1 receptor agonists.
Rybelsus is not for treating type 1 diabetes.
Rybelsus was first approved by the FDA on September 20, 2019.

Warnings

You should not use Rybelsus if you have multiple endocrine neoplasia type 2 (tumors in your glands), a personal or family history of medullary thyroid cancer, insulin-dependent diabetes, or diabetic ketoacidosis.
Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.

By staying on our site you automatically agree with the storage and processing of your personal data, in accordance with our Privacy Policy.